Nantahala Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Nantahala Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-820,825	Closed	-$12M	–	143
2023 Q1	$12M	Sell	820,825 -616,633	-43%	-$8.71M	0.92%	27
2022 Q4	$10.5M	Hold	1,437,458	–	–	0.68%	35
2022 Q3	$9.95M	Sell	1,437,458 -125,000	-8%	-$933K	0.64%	41
2022 Q2	$10.9M	Buy	1,562,458 +490,922	+46%	+$3.83M	0.55%	40
2022 Q1	$8.86M	Buy	+1,071,536	New	+$9.67M	0.39%	47

Nantahala Capital Management's AMYT Position: Q2 2023 in Review

Nantahala Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 820,825 shares — an estimated $12M sold.

Nantahala Capital Management first reported a position in AMYT in Q1 2022 and held it in 5 quarters. The position peaked at $12M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Nantahala Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Nantahala Capital Management sold 820,825 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $12M.
Nantahala Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
Nantahala Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $12M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Nantahala Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.